Descriptor English: | Promyelocytic Leukemia Nuclear Bodies | ||||||
Descriptor Spanish: |
Cuerpos Nucleares de la Leucemia Promielocítica
| ||||||
Descriptor Portuguese: | Corpos Nucleares da Leucemia Promielocítica | ||||||
Descriptor French: | Corps nucléaires de la leucémie promyélocytaire | ||||||
Entry term(s): |
Nuclear Bodies, PML Nuclear Body, PML PML Bodies PML Body PML NBs PML Nuclear Bodies PML Nuclear Body Promyelocytic Leukemia Nuclear Body Promyelocytic Leukemia Protein Bodies Promyelocytic Leukemia Protein Body |
||||||
Tree number(s): |
A11.284.430.106.279.345.574.875 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000088182 | ||||||
Scope note: | Spherical intranuclear membraneless bodies nucleated by PROMYELOCYTIC LEUKEMIA PROTEIN and various other proteins containing small ubiquitin-related modifier (SUMO) interaction motif (SIM) and/or sumoylated proteins (e.g., Sp100 protein). Promyelocytic leukemia nuclear bodies regulate posttranslational modifications of partner proteins (e.g., SUMOYLATION) which in turn lead to modulation of various biological processes. |
||||||
Allowable Qualifiers: |
CH chemistry CL classification DE drug effects EN enzymology GE genetics IM immunology ME metabolism MI microbiology PA pathology PH physiology PS parasitology RE radiation effects TR transplantation UL ultrastructure VI virology |
||||||
Previous Indexing: |
Intranuclear Inclusion Bodies (2008-2021) Promyelocytic Leukemia Protein (2008-2021) |
||||||
Public MeSH Note: | 2022 |
||||||
History Note: | 2022 |
||||||
DeCS ID: | 59668 | ||||||
Unique ID: | D000088182 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2022/01/01 | ||||||
Date of Entry: | 2021/07/09 | ||||||
Revision Date: | 2021/07/01 |
-
-
ANATOMY
Cells [A11]Cells
|
Promyelocytic Leukemia Nuclear Bodies
- Preferred
Concept UI |
M000740236 |
Scope note | Spherical intranuclear membraneless bodies nucleated by PROMYELOCYTIC LEUKEMIA PROTEIN and various other proteins containing small ubiquitin-related modifier (SUMO) interaction motif (SIM) and/or sumoylated proteins (e.g., Sp100 protein). Promyelocytic leukemia nuclear bodies regulate posttranslational modifications of partner proteins (e.g., SUMOYLATION) which in turn lead to modulation of various biological processes. |
Preferred term | Promyelocytic Leukemia Nuclear Bodies |
Entry term(s) |
Nuclear Bodies, PML Nuclear Body, PML PML Bodies PML Body PML NBs PML Nuclear Bodies PML Nuclear Body Promyelocytic Leukemia Nuclear Body Promyelocytic Leukemia Protein Bodies Promyelocytic Leukemia Protein Body |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey